Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy
Gespeichert in:
| Veröffentlicht in: | Leukemia 2020-04, Vol.34 (4), p.1177-1181 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1181 |
|---|---|
| container_issue | 4 |
| container_start_page | 1177 |
| container_title | Leukemia |
| container_volume | 34 |
| creator | Fürstenau, Moritz Hopfinger, Georg Robrecht, Sandra Fink, Anna-Maria Al-Sawaf, Othman Langerbeins, Petra Cramer, Paula Tresckow, Julia Von Maurer, Christian Kutsch, Nadine Hoechstetter, Manuela Dreyling, Martin Lange, Elisabeth Kneba, Michael Stilgenbauer, Stephan Döhner, Hartmut Hensel, Manfred Kiehl, Michael G. Jaeger, Ulrich Wendtner, Clemens-Martin Goede, Valentin Fischer, Kirsten von Bergwelt-Baildon, Michael Eichhorst, Barbara Hallek, Michael Theurich, Sebastian |
| description | |
| doi_str_mv | 10.1038/s41375-019-0630-6 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2474991673</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A619116587</galeid><sourcerecordid>A619116587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-d0776422b964b14002134807390ea8e914840ff8b58b984ea33ff2aec531b8b33</originalsourceid><addsrcrecordid>eNp9kk2LFDEQhhtR3HH1B3iRgCB66DXppPNxXAY_Fga86Dmk09XTWbuTMUmzzi_x75pmVtcFlRwqVD1vFVW8VfWc4AuCqXybGKGirTFRNeYU1_xBtSFM8LptW_Kw2mApRc1Vw86qJyldY7wW-ePqjBLRSNyKTfXjyg_TAt4CCgMKHSSXj8j4Hu3B9xBR8ChHMHkGn1FYsg0zJOQ8OpjsSi6hG5dHZMcYvLNoOs6HMdhjXv-wfIXZGfR6u9u9Qcvabx-c36Po8vLdzaarO5OgL2qYg5vnxYc8QjSH49Pq0WCmBM9u43n15f27z9uP9e7Th6vt5a62TMlc91gIzpqmU5x1hGHcEMokFlRhMBIUYZLhYZBdKzslGRhKh6ExYFtKOtlRel69PPU9xPBtgZT1dViiLyN1wwRTinDxf4rKMrBpWnVH7c0E2vkh5Gjs7JLVl5woQngrRaEu_kKV15db2eBhcCV_T_DqD8EIZspjCtOSXfDpPkhOoI0hpQiDPsRy5HjUBOvVMPpkGF0Mo1fDaF40L243W7oZ-t-KXw4pQHMCUin5PcS71f_d9SdfRMpm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2384802259</pqid></control><display><type>article</type><title>Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Fürstenau, Moritz ; Hopfinger, Georg ; Robrecht, Sandra ; Fink, Anna-Maria ; Al-Sawaf, Othman ; Langerbeins, Petra ; Cramer, Paula ; Tresckow, Julia Von ; Maurer, Christian ; Kutsch, Nadine ; Hoechstetter, Manuela ; Dreyling, Martin ; Lange, Elisabeth ; Kneba, Michael ; Stilgenbauer, Stephan ; Döhner, Hartmut ; Hensel, Manfred ; Kiehl, Michael G. ; Jaeger, Ulrich ; Wendtner, Clemens-Martin ; Goede, Valentin ; Fischer, Kirsten ; von Bergwelt-Baildon, Michael ; Eichhorst, Barbara ; Hallek, Michael ; Theurich, Sebastian</creator><creatorcontrib>Fürstenau, Moritz ; Hopfinger, Georg ; Robrecht, Sandra ; Fink, Anna-Maria ; Al-Sawaf, Othman ; Langerbeins, Petra ; Cramer, Paula ; Tresckow, Julia Von ; Maurer, Christian ; Kutsch, Nadine ; Hoechstetter, Manuela ; Dreyling, Martin ; Lange, Elisabeth ; Kneba, Michael ; Stilgenbauer, Stephan ; Döhner, Hartmut ; Hensel, Manfred ; Kiehl, Michael G. ; Jaeger, Ulrich ; Wendtner, Clemens-Martin ; Goede, Valentin ; Fischer, Kirsten ; von Bergwelt-Baildon, Michael ; Eichhorst, Barbara ; Hallek, Michael ; Theurich, Sebastian</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/s41375-019-0630-6</identifier><identifier>PMID: 31728057</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/1059/2325 ; 631/67/1059/99 ; 692/699/1541/1990/283/1895 ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Bendamustine Hydrochloride - administration & dosage ; Cancer Research ; Care and treatment ; Chronic lymphocytic leukemia ; Clinical Trials, Phase III as Topic ; Critical Care Medicine ; Demographic aspects ; Development and progression ; Female ; Follow-Up Studies ; Health aspects ; Hematology ; Humans ; Immunotherapy ; Immunotherapy - mortality ; Intensive ; Internal Medicine ; Letter ; Leukemia ; Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell - mortality ; Leukemia, Lymphocytic, Chronic, B-Cell - pathology ; Lymphatic leukemia ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Monoclonal antibodies ; Obesity ; Obesity - physiopathology ; Oncology ; Overweight persons ; Patient outcomes ; Prognosis ; Prospective Studies ; Rituximab ; Rituximab - administration & dosage ; Sex Factors ; Survival Rate ; Targeted cancer therapy ; Vidarabine - administration & dosage</subject><ispartof>Leukemia, 2020-04, Vol.34 (4), p.1177-1181</ispartof><rights>Springer Nature Limited 2019</rights><rights>COPYRIGHT 2020 Nature Publishing Group</rights><rights>2019© Springer Nature Limited 2019</rights><rights>Springer Nature Limited 2019.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-d0776422b964b14002134807390ea8e914840ff8b58b984ea33ff2aec531b8b33</citedby><cites>FETCH-LOGICAL-c498t-d0776422b964b14002134807390ea8e914840ff8b58b984ea33ff2aec531b8b33</cites><orcidid>0000-0001-9895-0570</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31728057$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fürstenau, Moritz</creatorcontrib><creatorcontrib>Hopfinger, Georg</creatorcontrib><creatorcontrib>Robrecht, Sandra</creatorcontrib><creatorcontrib>Fink, Anna-Maria</creatorcontrib><creatorcontrib>Al-Sawaf, Othman</creatorcontrib><creatorcontrib>Langerbeins, Petra</creatorcontrib><creatorcontrib>Cramer, Paula</creatorcontrib><creatorcontrib>Tresckow, Julia Von</creatorcontrib><creatorcontrib>Maurer, Christian</creatorcontrib><creatorcontrib>Kutsch, Nadine</creatorcontrib><creatorcontrib>Hoechstetter, Manuela</creatorcontrib><creatorcontrib>Dreyling, Martin</creatorcontrib><creatorcontrib>Lange, Elisabeth</creatorcontrib><creatorcontrib>Kneba, Michael</creatorcontrib><creatorcontrib>Stilgenbauer, Stephan</creatorcontrib><creatorcontrib>Döhner, Hartmut</creatorcontrib><creatorcontrib>Hensel, Manfred</creatorcontrib><creatorcontrib>Kiehl, Michael G.</creatorcontrib><creatorcontrib>Jaeger, Ulrich</creatorcontrib><creatorcontrib>Wendtner, Clemens-Martin</creatorcontrib><creatorcontrib>Goede, Valentin</creatorcontrib><creatorcontrib>Fischer, Kirsten</creatorcontrib><creatorcontrib>von Bergwelt-Baildon, Michael</creatorcontrib><creatorcontrib>Eichhorst, Barbara</creatorcontrib><creatorcontrib>Hallek, Michael</creatorcontrib><creatorcontrib>Theurich, Sebastian</creatorcontrib><title>Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy</title><title>Leukemia</title><addtitle>Leukemia</addtitle><addtitle>Leukemia</addtitle><subject>631/67/1059/2325</subject><subject>631/67/1059/99</subject><subject>692/699/1541/1990/283/1895</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Bendamustine Hydrochloride - administration & dosage</subject><subject>Cancer Research</subject><subject>Care and treatment</subject><subject>Chronic lymphocytic leukemia</subject><subject>Clinical Trials, Phase III as Topic</subject><subject>Critical Care Medicine</subject><subject>Demographic aspects</subject><subject>Development and progression</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Health aspects</subject><subject>Hematology</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Immunotherapy - mortality</subject><subject>Intensive</subject><subject>Internal Medicine</subject><subject>Letter</subject><subject>Leukemia</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - mortality</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - pathology</subject><subject>Lymphatic leukemia</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Monoclonal antibodies</subject><subject>Obesity</subject><subject>Obesity - physiopathology</subject><subject>Oncology</subject><subject>Overweight persons</subject><subject>Patient outcomes</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Rituximab</subject><subject>Rituximab - administration & dosage</subject><subject>Sex Factors</subject><subject>Survival Rate</subject><subject>Targeted cancer therapy</subject><subject>Vidarabine - administration & dosage</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kk2LFDEQhhtR3HH1B3iRgCB66DXppPNxXAY_Fga86Dmk09XTWbuTMUmzzi_x75pmVtcFlRwqVD1vFVW8VfWc4AuCqXybGKGirTFRNeYU1_xBtSFM8LptW_Kw2mApRc1Vw86qJyldY7wW-ePqjBLRSNyKTfXjyg_TAt4CCgMKHSSXj8j4Hu3B9xBR8ChHMHkGn1FYsg0zJOQ8OpjsSi6hG5dHZMcYvLNoOs6HMdhjXv-wfIXZGfR6u9u9Qcvabx-c36Po8vLdzaarO5OgL2qYg5vnxYc8QjSH49Pq0WCmBM9u43n15f27z9uP9e7Th6vt5a62TMlc91gIzpqmU5x1hGHcEMokFlRhMBIUYZLhYZBdKzslGRhKh6ExYFtKOtlRel69PPU9xPBtgZT1dViiLyN1wwRTinDxf4rKMrBpWnVH7c0E2vkh5Gjs7JLVl5woQngrRaEu_kKV15db2eBhcCV_T_DqD8EIZspjCtOSXfDpPkhOoI0hpQiDPsRy5HjUBOvVMPpkGF0Mo1fDaF40L243W7oZ-t-KXw4pQHMCUin5PcS71f_d9SdfRMpm</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Fürstenau, Moritz</creator><creator>Hopfinger, Georg</creator><creator>Robrecht, Sandra</creator><creator>Fink, Anna-Maria</creator><creator>Al-Sawaf, Othman</creator><creator>Langerbeins, Petra</creator><creator>Cramer, Paula</creator><creator>Tresckow, Julia Von</creator><creator>Maurer, Christian</creator><creator>Kutsch, Nadine</creator><creator>Hoechstetter, Manuela</creator><creator>Dreyling, Martin</creator><creator>Lange, Elisabeth</creator><creator>Kneba, Michael</creator><creator>Stilgenbauer, Stephan</creator><creator>Döhner, Hartmut</creator><creator>Hensel, Manfred</creator><creator>Kiehl, Michael G.</creator><creator>Jaeger, Ulrich</creator><creator>Wendtner, Clemens-Martin</creator><creator>Goede, Valentin</creator><creator>Fischer, Kirsten</creator><creator>von Bergwelt-Baildon, Michael</creator><creator>Eichhorst, Barbara</creator><creator>Hallek, Michael</creator><creator>Theurich, Sebastian</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><orcidid>https://orcid.org/0000-0001-9895-0570</orcidid></search><sort><creationdate>20200401</creationdate><title>Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy</title><author>Fürstenau, Moritz ; Hopfinger, Georg ; Robrecht, Sandra ; Fink, Anna-Maria ; Al-Sawaf, Othman ; Langerbeins, Petra ; Cramer, Paula ; Tresckow, Julia Von ; Maurer, Christian ; Kutsch, Nadine ; Hoechstetter, Manuela ; Dreyling, Martin ; Lange, Elisabeth ; Kneba, Michael ; Stilgenbauer, Stephan ; Döhner, Hartmut ; Hensel, Manfred ; Kiehl, Michael G. ; Jaeger, Ulrich ; Wendtner, Clemens-Martin ; Goede, Valentin ; Fischer, Kirsten ; von Bergwelt-Baildon, Michael ; Eichhorst, Barbara ; Hallek, Michael ; Theurich, Sebastian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-d0776422b964b14002134807390ea8e914840ff8b58b984ea33ff2aec531b8b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/67/1059/2325</topic><topic>631/67/1059/99</topic><topic>692/699/1541/1990/283/1895</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Bendamustine Hydrochloride - administration & dosage</topic><topic>Cancer Research</topic><topic>Care and treatment</topic><topic>Chronic lymphocytic leukemia</topic><topic>Clinical Trials, Phase III as Topic</topic><topic>Critical Care Medicine</topic><topic>Demographic aspects</topic><topic>Development and progression</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Health aspects</topic><topic>Hematology</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Immunotherapy - mortality</topic><topic>Intensive</topic><topic>Internal Medicine</topic><topic>Letter</topic><topic>Leukemia</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - mortality</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - pathology</topic><topic>Lymphatic leukemia</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Monoclonal antibodies</topic><topic>Obesity</topic><topic>Obesity - physiopathology</topic><topic>Oncology</topic><topic>Overweight persons</topic><topic>Patient outcomes</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Rituximab</topic><topic>Rituximab - administration & dosage</topic><topic>Sex Factors</topic><topic>Survival Rate</topic><topic>Targeted cancer therapy</topic><topic>Vidarabine - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fürstenau, Moritz</creatorcontrib><creatorcontrib>Hopfinger, Georg</creatorcontrib><creatorcontrib>Robrecht, Sandra</creatorcontrib><creatorcontrib>Fink, Anna-Maria</creatorcontrib><creatorcontrib>Al-Sawaf, Othman</creatorcontrib><creatorcontrib>Langerbeins, Petra</creatorcontrib><creatorcontrib>Cramer, Paula</creatorcontrib><creatorcontrib>Tresckow, Julia Von</creatorcontrib><creatorcontrib>Maurer, Christian</creatorcontrib><creatorcontrib>Kutsch, Nadine</creatorcontrib><creatorcontrib>Hoechstetter, Manuela</creatorcontrib><creatorcontrib>Dreyling, Martin</creatorcontrib><creatorcontrib>Lange, Elisabeth</creatorcontrib><creatorcontrib>Kneba, Michael</creatorcontrib><creatorcontrib>Stilgenbauer, Stephan</creatorcontrib><creatorcontrib>Döhner, Hartmut</creatorcontrib><creatorcontrib>Hensel, Manfred</creatorcontrib><creatorcontrib>Kiehl, Michael G.</creatorcontrib><creatorcontrib>Jaeger, Ulrich</creatorcontrib><creatorcontrib>Wendtner, Clemens-Martin</creatorcontrib><creatorcontrib>Goede, Valentin</creatorcontrib><creatorcontrib>Fischer, Kirsten</creatorcontrib><creatorcontrib>von Bergwelt-Baildon, Michael</creatorcontrib><creatorcontrib>Eichhorst, Barbara</creatorcontrib><creatorcontrib>Hallek, Michael</creatorcontrib><creatorcontrib>Theurich, Sebastian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fürstenau, Moritz</au><au>Hopfinger, Georg</au><au>Robrecht, Sandra</au><au>Fink, Anna-Maria</au><au>Al-Sawaf, Othman</au><au>Langerbeins, Petra</au><au>Cramer, Paula</au><au>Tresckow, Julia Von</au><au>Maurer, Christian</au><au>Kutsch, Nadine</au><au>Hoechstetter, Manuela</au><au>Dreyling, Martin</au><au>Lange, Elisabeth</au><au>Kneba, Michael</au><au>Stilgenbauer, Stephan</au><au>Döhner, Hartmut</au><au>Hensel, Manfred</au><au>Kiehl, Michael G.</au><au>Jaeger, Ulrich</au><au>Wendtner, Clemens-Martin</au><au>Goede, Valentin</au><au>Fischer, Kirsten</au><au>von Bergwelt-Baildon, Michael</au><au>Eichhorst, Barbara</au><au>Hallek, Michael</au><au>Theurich, Sebastian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy</atitle><jtitle>Leukemia</jtitle><stitle>Leukemia</stitle><addtitle>Leukemia</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>34</volume><issue>4</issue><spage>1177</spage><epage>1181</epage><pages>1177-1181</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>31728057</pmid><doi>10.1038/s41375-019-0630-6</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-9895-0570</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0887-6924 |
| ispartof | Leukemia, 2020-04, Vol.34 (4), p.1177-1181 |
| issn | 0887-6924 1476-5551 |
| language | eng |
| recordid | cdi_proquest_journals_2474991673 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | 631/67/1059/2325 631/67/1059/99 692/699/1541/1990/283/1895 Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bendamustine Hydrochloride - administration & dosage Cancer Research Care and treatment Chronic lymphocytic leukemia Clinical Trials, Phase III as Topic Critical Care Medicine Demographic aspects Development and progression Female Follow-Up Studies Health aspects Hematology Humans Immunotherapy Immunotherapy - mortality Intensive Internal Medicine Letter Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - mortality Leukemia, Lymphocytic, Chronic, B-Cell - pathology Lymphatic leukemia Male Medicine Medicine & Public Health Middle Aged Monoclonal antibodies Obesity Obesity - physiopathology Oncology Overweight persons Patient outcomes Prognosis Prospective Studies Rituximab Rituximab - administration & dosage Sex Factors Survival Rate Targeted cancer therapy Vidarabine - administration & dosage |
| title | Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A55%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20obesity%20and%20gender%20on%20treatment%20outcomes%20in%20patients%20with%20chronic%20lymphocytic%20leukemia%20(CLL)%20undergoing%20rituximab-based%20chemoimmunotherapy&rft.jtitle=Leukemia&rft.au=F%C3%BCrstenau,%20Moritz&rft.date=2020-04-01&rft.volume=34&rft.issue=4&rft.spage=1177&rft.epage=1181&rft.pages=1177-1181&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/s41375-019-0630-6&rft_dat=%3Cgale_proqu%3EA619116587%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2384802259&rft_id=info:pmid/31728057&rft_galeid=A619116587&rfr_iscdi=true |